Compass is still being developed and is effectively in beta. Some content and features may be incomplete, change, or not work as expected.

Content is anchored to trusted sources where available, but Compass has not yet been clinically reviewed. It provides general information rather than medical advice.

Feedback helps us identify gaps, errors, usability problems and opportunities to improve Compass over time.

How Compass is developedGive feedback

Different SOD1 mutations produced faster or slower disease patterns in mice

Original source

Fast and slow strains of misfolded mutant superoxide dismutase 1 in familial amyotrophic lateral sclerosis.Acta Neuropathol Commun · 25 February 2026 (opens in a new tab)

Compass summarised this from the study's abstract.

Study details

Studied in
Human, Mouse

Related topics

Misfolded forms of mutant superoxide dismutase 1 (SOD1) linked to rapidly progressing familial amyotrophic lateral sclerosis caused paralysis earlier in a mouse model than forms linked to slower disease. The findings suggest that different SOD1 “strains” may help explain why disease progression varies between mutations.

Why this matters

This may help researchers study how SOD1-related ALS begins and spreads. The work was conducted in transgenic mice and does not change treatment for people with ALS.

Limitations and context

This was a preclinical study in transgenic mice using injected spinal or nerve tissue. It tested a disease-seeding model rather than people with ALS, so it remains to be shown whether the proposed strain differences directly explain progression in patients or can guide treatment.

Summarised by Compass 12 August 2026

This summary was generated by AI from the source listed above. It is not medical advice, so read the original source for anything that affects your care.

Bibliographic data from PubMed is courtesy of the U.S. National Library of Medicine. Compass does not reproduce source abstracts and may not reflect the most current record.

Relevant to you?